ADRB2 and Hypertension: In summary, our results demonstrated that the percentage of leukocytes expressing TH and β2-AR was altered in arterial hypertension and can be modulated by central sympathetic inhibition with clonidine treatment, thus suggesting that the expression of these proteins could be candidates for the development of peripheral markers of the central sympathetic activity in primary arterial hypertension.